Father’s obesity may increase newborn’s risk for cancer later in life
Click Here to Manage Email Alerts
The link between maternal obesity and its effect on a newborn’s health status has recently been addressed in the literature. However, preliminary data published in BMC Medicine suggest that paternal obesity could lead to hypomethylation of insulin-like growth factor II, potentially increasing a newborn’s risk for developing cancer.
“During spermatogenesis, some regions in the DNA may be sensitive to environmental damage; these effects can be transmitted to the next generation. It is possible that malnutrition or hormone levels in obese fathers leads to incomplete DNA methylation or to unstable genomic imprinting of sperm cells,” researcher Adelheid Soubry, PhD, of Duke Cancer Institute, said in a press release.
Soubry and colleagues studied DNA from umbilical cord blood leukocytes of 79 newborns born between July 2005 and November 2006 at Duke University Hospital. During their pregnancy, the newborns’ mothers were enrolled in the Newborn Epigenetics Study (NEST). Besides questionnaires and medical records, Soubry and colleagues conducted bisulfite pyrosequencing of DNA methylation patterns at two differentially methylated regions (DMRs); one upstream of IGF-II, and the other upstream of the H19 gene. Further analysis was completed to determine the link between the newborns’ DNA methylation patterns and their parental obesity before conception.
According to data, hypomethylation at the IGF-II DMR was linked to paternal obesity before and after adjustments for several characteristics (P=.003). Furthermore, no significant relationship was found between methylation patterns and paternal obesity at the H19 DMR.
These findings suggest adverse lifestyle factors could have an effect during spermatogenesis. However, further research is needed to confirm the results, researchers said.
Disclosure: The researchers report no relevant financial disclosures.